Current and historical daily PE Ratio for Numinus Wellness Inc (
STU:LR23
) from 2020 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Numinus Wellness stock (STU:LR23) PE ratio as of Sep 21 2024 is 0.
More Details
Numinus Wellness Inc (STU:LR23) PE Ratio (TTM) Chart
Numinus Wellness Inc (STU:LR23) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 1001
- 1
- 2
- 3
- 4
- 5
- 6
- 12
| Numinus Wellness PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-22 | At Loss | 2024-07-22 | At Loss |
| 2024-09-20 | At Loss | 2024-07-19 | At Loss |
| 2024-09-19 | At Loss | 2024-07-18 | At Loss |
| 2024-09-18 | At Loss | 2024-07-17 | At Loss |
| 2024-09-17 | At Loss | 2024-07-16 | At Loss |
| 2024-09-16 | At Loss | 2024-07-15 | At Loss |
| 2024-09-13 | At Loss | 2024-07-12 | At Loss |
| 2024-09-12 | At Loss | 2024-07-11 | At Loss |
| 2024-09-11 | At Loss | 2024-07-10 | At Loss |
| 2024-09-10 | At Loss | 2024-07-09 | At Loss |
| 2024-09-09 | At Loss | 2024-07-08 | At Loss |
| 2024-09-06 | At Loss | 2024-07-05 | At Loss |
| 2024-09-05 | At Loss | 2024-07-04 | At Loss |
| 2024-09-04 | At Loss | 2024-07-03 | At Loss |
| 2024-09-03 | At Loss | 2024-07-02 | At Loss |
| 2024-09-02 | At Loss | 2024-07-01 | At Loss |
| 2024-08-30 | At Loss | 2024-06-28 | At Loss |
| 2024-08-29 | At Loss | 2024-06-27 | At Loss |
| 2024-08-28 | At Loss | 2024-06-26 | At Loss |
| 2024-08-27 | At Loss | 2024-06-25 | At Loss |
| 2024-08-26 | At Loss | 2024-06-24 | At Loss |
| 2024-08-23 | At Loss | 2024-06-21 | At Loss |
| 2024-08-22 | At Loss | 2024-06-20 | At Loss |
| 2024-08-21 | At Loss | 2024-06-19 | At Loss |
| 2024-08-20 | At Loss | 2024-06-18 | At Loss |
| 2024-08-19 | At Loss | 2024-06-17 | At Loss |
| 2024-08-16 | At Loss | 2024-06-14 | At Loss |
| 2024-08-15 | At Loss | 2024-06-13 | At Loss |
| 2024-08-14 | At Loss | 2024-06-12 | At Loss |
| 2024-08-13 | At Loss | 2024-06-11 | At Loss |
| 2024-08-12 | At Loss | 2024-06-10 | At Loss |
| 2024-08-09 | At Loss | 2024-06-07 | At Loss |
| 2024-08-08 | At Loss | 2024-06-06 | At Loss |
| 2024-08-07 | At Loss | 2024-06-05 | At Loss |
| 2024-08-06 | At Loss | 2024-06-04 | At Loss |
| 2024-08-05 | At Loss | 2024-06-03 | At Loss |
| 2024-08-02 | At Loss | 2024-05-31 | At Loss |
| 2024-08-01 | At Loss | 2024-05-30 | At Loss |
| 2024-07-31 | At Loss | 2024-05-29 | At Loss |
| 2024-07-30 | At Loss | 2024-05-28 | At Loss |
| 2024-07-29 | At Loss | 2024-05-27 | At Loss |
| 2024-07-26 | At Loss | 2024-05-24 | At Loss |
| 2024-07-25 | At Loss | 2024-05-23 | At Loss |
| 2024-07-24 | At Loss | 2024-05-22 | At Loss |
| 2024-07-23 | At Loss | 2024-05-21 | At Loss |
Numinus Wellness Inc (STU:LR23) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Numinus Wellness Inc
NAICS : 621399
SIC : 8613
ISIN : CA67054W1032
Share Class Description:
STU:LR23: Ordinary SharesCompare
Compare
Traded in other countries / regions
NUMI.CanadaNUMIF.USALR23.Germany IPO Date
2020-05-20Description
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers